z-logo
open-access-imgOpen Access
Franchising Rabies Vaccine Delivery: The Case of Indian Immunologicals
Author(s) -
Hassan Masum,
Hima Batavia,
Natasha Bhogal,
Kim Le,
Peter Singer
Publication year - 2011
Publication title -
plos neglected tropical diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.99
H-Index - 135
eISSN - 1935-2735
pISSN - 1935-2727
DOI - 10.1371/journal.pntd.0000946
Subject(s) - cold chain , business , poverty , credibility , rabies , economic growth , virology , medicine , economics , engineering , political science , mechanical engineering , law
K. V. Balasubramaniam of Indian Immunologicals Ltd. describes their motivation to develop one of the largest vaccine delivery franchises in the world, with over 3,000 locations across India: There's an inadequate or poor supply of free vaccines in the public health system, and we don't have universal credibility of the cold chain…so the poorer class near the poverty line has to go and stand in a queue to get the vaccine, to immunize their children. We wanted to bridge that gap. Give the quality, maintain cold chain, affordability, and proper availability throughout the country with a network of qualified people. …We deal with infrastructure that already exists because otherwise we cannot deal with rural costs. It won't be affordable anymore. —K. V. Balasubramaniam, Managing Director, Indian Immunologicals Ltd.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom